<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet><PubmedArticle><MedlineCitation Status="MEDLINE" IndexingMethod="Automated" Owner="NLM"><PMID Version="1">34379531</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>27</Day></DateCompleted><DateRevised><Year>2021</Year><Month>11</Month><Day>29</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-660X</ISSN><JournalIssue CitedMedium="Internet"><Volume>59</Volume><Issue>11</Issue><PubDate><Year>2021</Year><Month>10</Month><Day>19</Day></PubDate></JournalIssue><Title>Journal of clinical microbiology</Title><ISOAbbreviation>J Clin Microbiol</ISOAbbreviation></Journal><ArticleTitle>Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants.</ArticleTitle><Pagination><MedlinePgn>e0092121</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1128/JCM.00921-21</ELocationID><Abstract><AbstractText>We report that there is a recent global expansion of numerous independent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with mutation L452R in the receptor-binding domain (RBD) of the spike protein. The massive emergence of L452R variants was first linked to lineage B.1.427/B.1.429 (clade 21C) that has been spreading in California since November and December 2020, originally named CAL.20C and currently variant of interest epsilon. By PCR amplification and Sanger sequencing of a 541-base fragment coding for amino acids 414 to 583 of the RBD from a collection of clinical specimens, we identified a separate L452R variant that also recently emerged in California but derives from the lineage B.1.232, clade 20A (named CAL.20A). Notably, CAL.20A caused an infection in gorillas in the San Diego Zoo, reported in January 2021. Unlike the epsilon variant that carries two additional mutations in the N-terminal domain of spike protein, L452R is the only mutation found in the spike proteins of CAL.20A. Based on genome-wide phylogenetic analysis, emergence of both viral variants was specifically triggered by acquisition of L452R, suggesting a strong positive selection for this mutation. Global analysis revealed that L452R is nearly omnipresent in a dozen independently emerged lineages, including the most recent variants of concern/interest delta, kappa, epsilon and iota, with the lambda variant carrying L452Q. L452 is in immediate proximity to the angiotensin-converting enzyme 2 (ACE2) interaction interface of RBD. It was reported that the L452R mutation is associated with immune escape and could result in a stronger cell attachment of the virus, with both factors likely increasing viral transmissibility, infectivity, and pathogenicity.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tchesnokova</LastName><ForeName>Veronika</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>University of Washingtongrid.34477.33, Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ID Genomics, Inc., Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kulasekara</LastName><ForeName>Hemantha</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Lydia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University of Washingtongrid.34477.33, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bowers</LastName><ForeName>Victoria</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>ARMADA (The Antibiotic Resistance Monitoring, Analysis and Diagnostics Alliance), Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rechkina</LastName><ForeName>Elena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>ID Genomics, Inc., Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kisiela</LastName><ForeName>Dagmara</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>University of Washingtongrid.34477.33, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sledneva</LastName><ForeName>Yulia</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>ID Genomics, Inc., Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choudhury</LastName><ForeName>Debarati</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>ID Genomics, Inc., Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maslova</LastName><ForeName>Iryna</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>ID Genomics, Inc., Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deng</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kutumbaka</LastName><ForeName>Kirthi</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Hao</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fowler</LastName><ForeName>Curtis</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greene</LastName><ForeName>Dina</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington (KPWA), Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KPWA Research Institute, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ralston</LastName><ForeName>James</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Kaiser Permanente Washington (KPWA), Seattle, Washington, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>KPWA Research Institute, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Samadpour</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>IEH Laboratories and Consulting Group, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sokurenko</LastName><ForeName>Evgeni</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2806-4121</Identifier><AffiliationInfo><Affiliation>University of Washingtongrid.34477.33, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>n/a</GrantID><Agency>ARMADA Foundation</Agency><Country/></Grant><Grant><GrantID>n/a</GrantID><Agency>ID Genomics</Agency><Country/></Grant><Grant><Agency>IEH Laboratories and Consulting Group</Agency><Country/></Grant><Grant><GrantID>R01AI106007</GrantID><Agency>HHS | National Institutes of Health (NIH)</Agency><Country/></Grant><Grant><GrantID>R01 AI106007</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>08</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Microbiol</MedlineTA><NlmUniqueID>7505564</NlmUniqueID><ISSNLinking>0095-1137</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064370">Spike Glycoprotein, Coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>bioRxiv. 2021 Mar 11;:</RefSource><PMID Version="1">33758861</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010802" MajorTopicYN="N">Phylogeny</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064370" MajorTopicYN="N">Spike Glycoprotein, Coronavirus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">L452R</Keyword><Keyword MajorTopicYN="Y">SARS-CoV-2</Keyword><Keyword MajorTopicYN="Y">expansion</Keyword><Keyword MajorTopicYN="Y">mutation</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>17</Hour><Minute>14</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34379531</ArticleId><ArticleId IdType="doi">10.1128/JCM.00921-21</ArticleId><ArticleId IdType="pmc">PMC8525575</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pathogens. 2021 Feb 09;10(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">33572190</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Rep. 2021 Jan 26;34(4):108666</Citation><ArticleIdList><ArticleId IdType="pubmed">33503420</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Apr 6;325(13):1324-1326</Citation><ArticleIdList><ArticleId IdType="pubmed">33571356</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2020 Oct 14;11:585354</Citation><ArticleIdList><ArticleId IdType="pubmed">33163000</ArticleId></ArticleIdList></Reference><Reference><Citation>J Mol Biol. 2020 Sep 4;432(19):5212-5226</Citation><ArticleIdList><ArticleId IdType="pubmed">32710986</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Sep 3;182(5):1284-1294.e9</Citation><ArticleIdList><ArticleId IdType="pubmed">32730807</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Immunol. 2021 Jun 04;12:691715</Citation><ArticleIdList><ArticleId IdType="pubmed">34149735</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2021 Jul 14;29(7):1124-1136.e11</Citation><ArticleIdList><ArticleId IdType="pubmed">34171266</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Apr 6;325(13):1261-1262</Citation><ArticleIdList><ArticleId IdType="pubmed">33571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2021 Jun 24;184(13):3426-3437.e8</Citation><ArticleIdList><ArticleId IdType="pubmed">33991487</ArticleId></ArticleIdList></Reference><Reference><Citation>Science. 2021 Aug 6;373(6555):648-654</Citation><ArticleIdList><ArticleId IdType="pubmed">34210893</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6</Citation><ArticleIdList><ArticleId IdType="pubmed">33592168</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell. 2020 Dec 10;183(6):1735</Citation><ArticleIdList><ArticleId IdType="pubmed">33306958</ArticleId></ArticleIdList></Reference><Reference><Citation>iScience. 2021 Feb 19;24(2):102116</Citation><ArticleIdList><ArticleId IdType="pubmed">33532709</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Commun. 2021 Jan 20;12(1):469</Citation><ArticleIdList><ArticleId IdType="pubmed">33473140</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Immunol. 2021 Jan;222:108634</Citation><ArticleIdList><ArticleId IdType="pubmed">33217545</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2021 Feb 9;325(6):529-531</Citation><ArticleIdList><ArticleId IdType="pubmed">33404586</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>